Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X:
“FDA grants traditional approval to encorafenib + cetuximab + fluorouracil-based chemotherapy for BRAF V600E metastatic CRC.”
Other articles featuring Ahmet Dirican on OncoDaily